Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 9
Summary
- Conditions
- Acute Lymphoblastic Leukemia in Remission
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Other Acute Leukemias
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03483324
- Collaborators
- California Institute for Regenerative Medicine (CIRM)
- Investigators
- Study Director: Paul Finegan, MD Angiocrine Bioscience Principal Investigator: Juliet Barker, MBBS Memorial Sloan Kettering Cancer Center
Get Well Soon